tirzepatide peptide science – 30mg – Prime Lab Peptides Tirzepatide
Description
How the Study Was Conducted The trial was conducted at the Mental Health Centre Copenhagen in Denmark and lasted 26 weeks
16 January 2024
Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research
Diabetologia 62:665675 Bergmann NC et al (2020) No acute effects of exogenous glucose-dependent insulinotropic polypeptide on energy intake, appetite, or energy expenditure when added to treatment with a long-acting glucagon-like peptide 1 receptor agonist in men with type 2 diabetes
It makes me worry about how weight is tied to peoples self-worth
GLP-1s have become a popular medication so much so that, for a couple of years, there was a national shortage
